Your browser doesn't support javascript.
loading
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.
Kartnig, Felix; Mrak, Daniel; Simader, Elisabeth; Tobudic, Selma; Radner, Helga; Mandl, Peter; Göschl, Lisa; Hommer, Nikolaus; Mayer, Margareta; Hofer, Philipp; Hummel, Thomas; Deimel, Thomas; Geßl, Irina; Puchner, Antonia; Kerschbaumer, Andreas; Thalhammer, Renate; Handisurya, Alessandra; Kain, Renate; Winkler, Stefan; Smolen, Josef S; Stiasny, Karin; Perkmann, Thomas; Haslacher, Helmuth; Aberle, Judith H; Aletaha, Daniel; Heinz, Leonhard X; Sieghart, Daniela; Bonelli, Michael.
Afiliación
  • Kartnig F; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Mrak D; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Simader E; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Tobudic S; Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Radner H; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Mandl P; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Göschl L; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Hommer N; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Mayer M; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Hofer P; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Hummel T; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Deimel T; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Geßl I; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Puchner A; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kerschbaumer A; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Thalhammer R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Handisurya A; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Kain R; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Winkler S; Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Smolen JS; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Stiasny K; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Aberle JH; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Aletaha D; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Heinz LX; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Sieghart D; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Bonelli M; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria michael.bonelli@meduniwien.ac.at.
Ann Rheum Dis ; 82(2): 292-300, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36109141

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: Austria
...